CapsoVision (CV) Change in Receivables (2024 - 2025)
CapsoVision (CV) posted Change in Receivables of $629000.0 for Q4 2025, up 3831.25% sequentially from $16000.0 in Q3 2025, and up 51.93% YoY from $414000.0 in Q4 2024.
CapsoVision (CV) Change in Receivables (2024 - 2025) Analysis & Trends
CapsoVision has reported Change in Receivables for 2 years, with the latest figure at $629000.0 in Q4 2025.
- Quarterly Change in Receivables rose 51.93% year-over-year to $629000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.1 million (changed N/A YoY) and the FY2025 annual result came in at $478000.0, up 171.59% from the prior year.
- Change in Receivables climbed to $629000.0 in Q4 2025 per CV's latest filing, from $16000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $629000.0 in Q4 2025 and troughed at -$2000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -90.00 Mn |
| 10 | CapsoVision | 299.87 Mn | 290.80 Mn | 1.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 629,000.00 |
| Dec 31, 2025 | 629,000.00 |
| Sep 30, 2025 | 16,000.00 |
| Sep 30, 2025 | 16,000.00 |
| Dec 31, 2024 | 414,000.00 |
| Dec 31, 2024 | 414,000.00 |
| Sep 30, 2024 | -2,000.00 |
| Sep 30, 2024 | -2,000.00 |